Juan José López Núñez (@juanjolopezn) 's Twitter Profile
Juan José López Núñez

@juanjolopezn

Internal medicine Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.

ID: 943646359198027776

calendar_today21-12-2017 00:56:38

974 Tweet

330 Followers

207 Following

American College of Cardiology (@accintouch) 's Twitter Profile Photo

Extended anticoagulant therapy with reduced-dose apixaban was noninferior to full-dose in patients with active cancer and #cvVTE, based on findings from the API-CAT trial presented at #ACC25. Read the journal scan to learn more: bit.ly/4jebhJd

Extended anticoagulant therapy with reduced-dose apixaban was noninferior to full-dose in patients with active cancer and #cvVTE, based on findings from the API-CAT trial presented at #ACC25.

Read the journal scan to learn more: bit.ly/4jebhJd
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Dr. Mahé Isabelle on the extended anticoagulant treatment with a reduced versus full dose #apixaban in patients with cancer-associated #VTE #ACC25 #JACCJournals #APICAT #CardioOnc #cvCoag

Dr. <a href="/isabellemahe1/">Mahé Isabelle</a> on the extended anticoagulant treatment with a reduced versus full dose #apixaban in patients with cancer-associated #VTE

#ACC25 #JACCJournals #APICAT #CardioOnc #cvCoag
OncoDaily (@oncodaily) 's Twitter Profile Photo

New Paper Alert: Reduced-Dose Apixaban Found Effective for Extended Treatment of Cancer-Associated VTE Mahé Isabelle Marc Carrier Mayeur Didier Juan José López Núñez Robert-Ebadi Helia oncodaily.com/oncolibrary/re… #AnticoagulantTherapy #Apixaban #CancerCare #MedX #MedEd #OncoDaily #Oncology

Hosp. Germans Trias (@hgermanstrias) 's Twitter Profile Photo

🆕 Participem d’un estudi que, per primera vegada, demostra poder reduir la dosi d’un anticoagulant en el tractament estès de pacients amb trombosi associada a càncer 👨‍⚕️ Juan José López (esquerra a la 📸), ha coordinat a Espanya l'assaig clínic multicèntric internacional API-CAT

🆕 Participem d’un estudi que, per primera vegada, demostra poder reduir la dosi d’un anticoagulant en el tractament estès de pacients amb trombosi associada a càncer

👨‍⚕️ Juan José López (esquerra a la 📸), ha coordinat a Espanya l'assaig clínic multicèntric internacional API-CAT
Pablo Demelo, MD, PhD (@pablodemelo) 's Twitter Profile Photo

🧵 Uno de los ídolos de mi infancia, Fernando Morientes, ha sufrido una embolia pulmonar. En la Unidad de Trombosis del H. Gregorio Marañón (Unidad de ETV Hospital Gregorio Marañón) tratamos esta patología a diario. Breve hilo sobre la embolia pulmonar y los viajes en avión: ✈️🩺

manuel monreal (@mmonrealriete) 's Twitter Profile Photo

Our multimarker calculator to predict 30-day outcomes in acute PE, already published in Eur Heart J Congratulations, David and team!

Our multimarker calculator to predict 30-day outcomes in acute PE, already published in Eur Heart J

Congratulations, David and team!
manuel monreal (@mmonrealriete) 's Twitter Profile Photo

We included the Samanta score into the #RIETEregistry one month ago So far, we have collected data on 44 women aged <50 y We will learn how anticoagulation impacts on menstrual bleeds, which women, which drugs, how to prevent excessive bleeds, and how to manage it Stay tuned

Behnood Bikdeli (@bbikdeli) 's Twitter Profile Photo

Need to do better for #PE risk stratification, beyond reductionist models. In an European Society of Cardiology Journals #EHJ paper we show that a multimarker calculator🌡️outperforms the ESC model. Great work by David Jiménez 🇪🇸 manuel monreal et al #RIETE! Honored to be a part of it 👇: tinyurl.com/trpmzbrd

Need to do better for #PE risk stratification, beyond reductionist models. In an <a href="/ESC_Journals/">European Society of Cardiology Journals</a> #EHJ paper we show that a multimarker  calculator🌡️outperforms the ESC model. Great work by <a href="/DJC6998/">David Jiménez 🇪🇸</a> <a href="/mmonrealriete/">manuel monreal</a> et al #RIETE! Honored to be a part of it 👇:
 tinyurl.com/trpmzbrd
Juan José López Núñez (@juanjolopezn) 's Twitter Profile Photo

Gracias a SeparRespira por invitarme a hablar sobre el tratamiento de la ETV en el paciente con cáncer de pulmón en el Congreso Nacional de la SEPAR de Bilbao. #ETV #cancer #bilbao SEPAR Circulación Pulmonar Hosp. Germans Trias

Gracias a <a href="/SeparRespira/">SeparRespira</a> por invitarme a hablar sobre el tratamiento de la ETV en el paciente con cáncer de pulmón en el Congreso Nacional de la SEPAR de Bilbao.
#ETV #cancer #bilbao <a href="/SeparCPulmonar/">SEPAR Circulación Pulmonar</a> <a href="/hgermanstrias/">Hosp. Germans Trias</a>